Trial Profile
A Multi-Center, Randomized, Double-Masked Clinical Study Evaluating the Efficacy Of FST-201 (Dexamethasone 0.1%) Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex (Ciprofloxacin 0.3%, Dexamethasone 0.1%) Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 28 May 2021
Price :
$35
*
At a glance
- Drugs Povidone iodine/dexamethasone (Primary) ; Ciprofloxacin/dexamethasone
- Indications Otitis externa
- Focus Therapeutic Use
- 19 Jul 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 09 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 09 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.